MDM2 Enhances the Function of Estrogen Receptor α in Human Breast Cancer Cells
- 1 February 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 281 (1), 259-265
- https://doi.org/10.1006/bbrc.2001.4339
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Overexpression of MDM2 in MCF-7 Promotes Both Growth Advantage and p53 Accumulation in Response to EstradiolJapanese Journal of Cancer Research, 1999
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- mdm2 gene alterations and mdm2 protein expression in breast carcinomasThe Journal of Pathology, 1995
- MDM2 gene amplification in human breast cancerEuropean Journal Of Cancer, 1994
- The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING fingerTrends in Biochemical Sciences, 1994
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986